Seven Eight Capital’s Astera Labs ALAB Stock Holding History

Seven Eight Capital’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,434	Closed	-$994K	–	987
2024 Q2	$994K	Buy	+16,434	New	+$1.14M	0.1%	363

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Seven Eight Capital's ALAB Position: Q3 2024 in Review

Seven Eight Capital sold out of Astera Labs (ALAB) in Q3 2024, closing a stake of 16,434 shares — an estimated $994K sold.

Seven Eight Capital first reported a position in ALAB in Q2 2024 and held it in 1 quarter. The position peaked at $994K in Q2 2024. 244 funds tracked by Wall St. Rank hold ALAB as of Q3 2024.

Seven Eight Capital reported no remaining Astera Labs position as of Q3 2024 after selling out during the quarter.
Seven Eight Capital sold 16,434 Astera Labs shares in Q3 2024, an estimated $994K.
Seven Eight Capital first reported a position in Astera Labs in Q2 2024 and held it in 1 quarter.
Seven Eight Capital's Astera Labs position peaked at $994K in Q2 2024.
244 funds tracked by Wall St. Rank held Astera Labs as of Q3 2024.

Based on Seven Eight Capital's 13F filing for Q3 2024, filed 12 Nov 2024.